Efficacy Of Pencil Pushup Exercise Vs Base Out Exercising Prism's In Patient With Convergence Insufficiency
NCT ID: NCT06913829
Last Updated: 2025-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
28 participants
INTERVENTIONAL
2025-03-20
2026-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Three Vision Therapy Approaches for Convergence Insufficiency
NCT03431454
Home Vision Therapy and Prism Prescription in Presbyopic Persons With Convergence Insufficiency
NCT05311917
Effects of Forward Head Posture Correction on Visual Acuity in Low Level Visually Impaired University Students
NCT06019806
Effects Of Optimized Blinking Training on Visual Function and Tear Film Parameters in Individuals With CVS
NCT06913816
Convergence Insufficiency Treatment Study (CITS)
NCT01515943
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
base-out exercising prisms
base-out exercising prisms
Participants in the experimental group will use base-out exercising prisms as their primary intervention. This involves:
1. Procedure:
* Wearing customized prism glasses designed to increase the convergence demand during near tasks.
* Performing near vision activities such as reading or viewing objects while wearing the prisms.
2. Schedule:
* Prisms will be prescribed based on individual clinical measurements.
* Participants will use the prisms during near tasks for 15-20 minutes daily, 5 days a week, for a total duration of 6 weeks.
3. Monitoring:
* Initial training will be provided to ensure proper use of the prisms.
* Adherence will be checked during weekly follow-up visits, where adjustments to the prism strength will be made if necessary.
pencil pushup exercises
pencil pushup exercises
Participants in the control group will perform pencil pushup exercises as their primary intervention. This involves: 1. Procedure: o Holding a pencil or similar object vertically at arm's length and focusing on a letter or small mark on it. o Gradually moving the pencil closer to the nose until the participant experiences visual blur or sees double. o Returning the pencil to the starting position and repeating the process. 2. Schedule: o Exercises will be prescribed for 15-20 minutes daily, 5 days a week, for a total duration of 6 weeks. 3. Monitoring: o Participants will receive instructions during the initial session and periodic supervision at follow-up visits to ensure proper technique and adherence. o Progress will be monitored weekly through symptom reporting and clinical measurements.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
base-out exercising prisms
Participants in the experimental group will use base-out exercising prisms as their primary intervention. This involves:
1. Procedure:
* Wearing customized prism glasses designed to increase the convergence demand during near tasks.
* Performing near vision activities such as reading or viewing objects while wearing the prisms.
2. Schedule:
* Prisms will be prescribed based on individual clinical measurements.
* Participants will use the prisms during near tasks for 15-20 minutes daily, 5 days a week, for a total duration of 6 weeks.
3. Monitoring:
* Initial training will be provided to ensure proper use of the prisms.
* Adherence will be checked during weekly follow-up visits, where adjustments to the prism strength will be made if necessary.
pencil pushup exercises
Participants in the control group will perform pencil pushup exercises as their primary intervention. This involves: 1. Procedure: o Holding a pencil or similar object vertically at arm's length and focusing on a letter or small mark on it. o Gradually moving the pencil closer to the nose until the participant experiences visual blur or sees double. o Returning the pencil to the starting position and repeating the process. 2. Schedule: o Exercises will be prescribed for 15-20 minutes daily, 5 days a week, for a total duration of 6 weeks. 3. Monitoring: o Participants will receive instructions during the initial session and periodic supervision at follow-up visits to ensure proper technique and adherence. o Progress will be monitored weekly through symptom reporting and clinical measurements.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with convergence insufficiency based on clinical tests (e.g., near point of convergence).
* Age group: 10-50
* Patients experiencing symptoms related to convergence insufficiency, such as eye strain, headaches, blurred vision, or double vision during near work.
* Able to perform pencil push-up exercises correctly after demonstration.
* No other significant ocular or neurological conditions that might affect vision or convergence.
Exclusion Criteria
* Amblyopia.
* Refractive error more than 6 diopters.
* Patients with history of prism prescription.
* History of strabismus surgery or refractive error surgery.
* History of eye trauma.
* Any systemic and neurological diseases affecting binocular vision such as diabetes, myasthenia gravis, Graves', and multiple sclerosis.
10 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Superior University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Muhammad Naveed Babur
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SIGHTON Optix Mozang Chungi
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MSRSW/Batch-Fall23/811
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.